Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol lock therapy for CABSI prevention in children with short bowel syndrome
NCT01263574Phase 2Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Feb 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ethanol in catheter-related bloodstream infection (CRBSI) (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Catheter associated blood stream infection. Planned start Feb 2011; status: withdrawn.
02
Drugs
ethanol
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT01263574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263574.